IFNG and infection: In previous studies of a Dutch population that experienced a high incidence of Cb exposure and infection, ex vivo measurement of IFNγ release by peripheral lymphocytes provided a more sensitive means of detecting known Cb exposure up to 10–14 years after initial exposure than did serological assays or the standard Q-VAX skin test [30,31,33].